Scarica l'app Stockscreener
3.88
2.37%
0.09
Dopo l'orario di chiusura:
3.83
-0.05
-1.29%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRVI Giù?
Forum
Previsione
Precedente Chiudi:
$3.79
Aprire:
$3.82
Volume 24 ore:
1.86M
Relative Volume:
1.25
Capitalizzazione di mercato:
$562.69M
Reddito:
$288.95M
Utile/perdita netta:
$-119.03M
Rapporto P/E:
-4.3087
EPS:
-0.9005
Flusso di cassa netto:
$60.67M
1 W Prestazione:
+18.65%
1M Prestazione:
+4.86%
6M Prestazione:
+45.32%
1 anno Prestazione:
-34.79%
Intervallo 1D:
$3.7816
$4.015
Intervallo di 1 settimana:
$3.19
$4.015
Portata 52W:
$1.665
$6.21
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Nome
Maravai Lifesciences Holdings Inc
Settore
Industria
Telefono
(858) 546-0004
Indirizzo
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Confronta MRVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
3.88 | 549.64M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Neutral |
| 2024-12-05 | Downgrade | Goldman | Neutral → Sell |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-08 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Iniziato | Craig Hallum | Buy |
| 2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-08-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Downgrade | Goldman | Buy → Neutral |
| 2023-01-05 | Downgrade | UBS | Buy → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-11-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2020-12-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Iniziato | BofA Securities | Buy |
| 2020-12-15 | Iniziato | Credit Suisse | Outperform |
| 2020-12-15 | Iniziato | Goldman | Buy |
| 2020-12-15 | Iniziato | Jefferies | Buy |
| 2020-12-15 | Iniziato | Robert W. Baird | Outperform |
| 2020-12-15 | Iniziato | Stifel | Buy |
| 2020-12-15 | Iniziato | William Blair | Outperform |
| 2020-12-14 | Iniziato | UBS | Buy |
Mostra tutto
Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie
Volume Summary: Can Maravai LifeSciences Holdings Inc stock withstand economic slowdownJuly 2025 Analyst Calls & Consistent Profit Alerts - moha.gov.vn
A US$75m Market Cap Boost Pleasing ToMaravai LifeSciences Holdings Insiders - simplywall.st
Maravai LifeSciences (NASDAQ:MRVI) Nasdaq Index Life Sciences Inputs - Kalkine Media
Maravai LifeSciences (NASDAQ:MRVI) Trading Up 11.3%Time to Buy? - MarketBeat
Ideas Watch: Is Maravai LifeSciences Holdings Inc. stock resilient to inflationMarket Volume Summary & Weekly Stock Performance Updates - moha.gov.vn
Maravai LifeSciences Holdings Inc Stock Analysis and ForecastRSI Overbought/Oversold & Free Superior Trading Gains - earlytimes.in
Critical Analysis: Maravai LifeSciences (NASDAQ:MRVI) versus TerrAscend (OTCMKTS:TSNDF) - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Investors Buy Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Shares Down 4.7%What's Next? - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Nasdaq 100 Index Life Science Scope - Kalkine Media
Can Maravai LifeSciences Holdings Inc. (MAR) stock survive global slowdownEarnings Performance Report & Capital Efficient Trade Techniques - Улправда
Does Maravai LifeSciences Holdings Inc. stock trade at a discount to peersTrade Entry Report & AI Optimized Trade Strategies - Улправда
Shorts Report: How Maravai LifeSciences Holdings Inc. (MAR) stock gains from tech spendingJuly 2025 Chart Watch & Expert Approved Trade Ideas - Улправда
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
2025-12-18 | Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation | NDAQ:MRVI | Press Release - Stockhouse
Can Maravai LifeSciences Holdings Inc. stock attract ESG capital inflowsOil Prices & Free Verified High Yield Trade Plans - Улправда
How Maravai LifeSciences Holdings Inc. (MAR) stock gains from tech spendingDip Buying & High Conviction Trade Alerts - Улправда
Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire
Why Analysts See Maravai’s Story Shifting After Target Cut And Washed Out Share Price Range - Yahoo Finance
Wells Fargo maintains Maravai LifeSciences Holdings (MRVI) overweight recommendation - MSN
MRVI: Wells Fargo Maintains Rating and Raises Price Target | MRV - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences LawsuitMRVI - ACCESS Newswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMRVI - 28/22 News
Maravai LifeSciences Holdings, Inc. $MRVI Stock Holdings Boosted by Immersion Corp - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Up Following Insider Buying Activity - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) Director Purchases $190,446.40 in Stock - MarketBeat
Maravai Lifesciences (MRVI) Director Acquires 100K Shares - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-12-09 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation | NDAQ:MRVI | Press Release - Stockhouse
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Maravai LifeSciences delivers 60% return after March fair value alert By Investing.com - Investing.com Canada
Maravai LifeSciences delivers 60% return after March fair value alert - Investing.com
Harspring Capital Management LLC Acquires New Shares in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Geode Capital Management LLC Has $7.19 Million Stock Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect - ACCESS Newswire
Will Maravai LifeSciences Holdings Inc. (MAR) stock justify high valuationPortfolio Profit Report & Precise Swing Trade Alerts - Newser
Will Maravai LifeSciences Holdings Inc. (MAR) stock sustain dividend payouts2025 Investor Takeaways & Weekly Consistent Profit Watchlists - Newser
Maravai LifeSciences Reports Q3 2025 Financial Results - MSN
A new trading data show Maravai LifeSciences Holdings Inc (MRVI) is showing positive returns. - Setenews
Maravai LifeSciences (MRVI) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Down 6.5%Here's What Happened - MarketBeat
Can Maravai LifeSciences Holdings Inc. (MAR) stock test all time highs2025 Investor Takeaways & Daily Stock Trend Watchlist - Newser
Why Analysts See Opportunity and Risk as Maravai’s Story Evolves After Management Shakeup - Yahoo Finance
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Analysts - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Maravai Lifesciences Holdings Inc Azioni (MRVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):